Diabetes mellitus Posts on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Evaluating combination therapy versus metformin only for patients with Type 2 diabetes

Posted by on Nov 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated whether adding vildagliptin (Galvus) to metformin (Glucophage) could improve the duration of blood glucose control for patients with newly diagnosed Type 2 Diabetes (T2D). The authors found that this treatment combination improved long-term blood glucose control for these patients. Some background...

Read More

Do glucagon-like peptide-1 receptor agonist drugs reduce heart disease and stroke in patients with diabetes?

Posted by on Nov 11, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs could reduce the rate of heart disease and stroke in patients with Type 2 diabetes (T2D). The authors found that fewer patients who received GLP-1RA drugs developed heart disease or stroke compared to those who received a placebo. Some background...

Read More

Can dapagliflozin help improve blood magnesium levels in patients with Type 2 diabetes?

Posted by on Nov 6, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effects of dapagliflozin (Forxiga) on blood magnesium levels in patients with type 2 diabetes (T2D). The authors concluded that dapagliflozin treatment helped improve blood magnesium levels in these patients. Some background T2D is associated with a number of other health complications. Patients with T2D...

Read More

Evaluating the Diabeloop insulin delivery system for patients with type 1 diabetes

Posted by on Nov 3, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is comparing the effectiveness of two insulin delivery systems for patients with type 1 diabetes (T1D). The authors concluded that the Diabeloop system was more effective and better reduced high blood glucose levels in these patients. Some background Controlling blood glucose levels is an essential part of diabetes management....

Read More

Looking for patients with diabetes mellitus to try an experimental treatment for fatty liver disease

Posted by on Oct 31, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is evaluating the effects of Aramchol on the outcomes of patients with diabetes mellitus who have fatty liver disease. The main outcome to be measured will be the number of patients who have minimal to no symptoms of disease after treatment. This study is recruiting in Arlington, Texas, US. The details About 40 – 50% of...

Read More

How effective and safe is a closed-loop insulin pump for patients with type 1 diabetes?

Posted by on Oct 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of a closed-loop and sensor-augmented insulin pumps for patients with Type 1 diabetes (T1D). The authors found that the closed-loop device was more effective but had more side effects for these patients. Some background The main goal of treatment for T1D is to balance blood glucose...

Read More

Evaluating the impact of weight regain on outcomes for patients with type 2 diabetes

Posted by on Oct 27, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the impact of weight regain on the outcomes of patients with type 2 diabetes (T2D). The authors concluded that patients who kept off the weight they lost had the greatest benefit compared to patients who regained lost weight. Some background Weight management is an essential part of T2D management. Many patients...

Read More

Looking for patients with diabetes to try an education program with nutritional supplements to prevent retinal disease

Posted by on Oct 19, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is evaluating the impact of an education program plus nutritional supplements on the frequency of eye disease in patients with diabetes mellitus. The main outcome to be measured will be the changes in electroretinogram results, a lab test that measures vision quality. This study is recruiting in North Carolina. The...

Read More

Can ipragliflozin treatment help lower insulin dose in patients with T2D receiving insulin therapy?

Posted by on Oct 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of ipragliflozin (Suglat) in patients with type 2 diabetes (T2D). This study concluded that ipragliflozin helped reduce insulin dose by 30%, with minimal side effects. Some background Treatment for T2D aims to achieve good blood glucose control while avoiding hypoglycemia (dangerously low...

Read More

Can a three-meal diet improve glucose control better than a six-meal diet for patients with T2D?

Posted by on Oct 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study investigated whether 3 meals a day improved blood glucose control and weight loss compared to 6 meals a day for patients with Type 2 diabetes (T2D). This study found that fewer meals a day improved blood glucose control and weight loss and reduced hunger and cravings. Some background Controlling blood sugar levels is a...

Read More

GLP-1 receptor agonists for diabetes: a review of the cardiovascular, kidney and mortality outcomes

Posted by on Oct 12, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the effects of glucagon-like peptide 1 receptor agonists (GLP-1Ra) in patients with diabetes.  They found that GLP-1Ra drugs improved cardiovascular (CV), kidney and mortality outcomes.  Some background Type 2 diabetes (T2D) is caused by a reduced response to insulin. This is called insulin...

Read More

What factors protect patients with type 2 diabetes from diabetic retinopathy?

Posted by on Oct 9, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the risk factors associated with diabetic retinopathy (DR). The authors concluded that factors such as age, total cholesterol, and the presence of other health complications could increase the risk of DR in patients with Type 2 diabetes (T2D). Some background T2D can lead to a number of other health...

Read More